PND98 - DETERMINING THE VALUE OF OCREVUS® (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2064
https://www.valueinhealthjournal.com/article/S1098-3015(18)35366-X/fulltext
Title :
PND98 - DETERMINING THE VALUE OF OCREVUS® (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35366-X&doi=10.1016/j.jval.2018.09.2064
First page :
Section Title :
Open access? :
No
Section Order :
1418